Antibiotic News and Research

RSS
Haiti cholera epidemic abates

Haiti cholera epidemic abates

Enrollment complete in ViroPharma's Phase 2 study evaluating subcutaneous delivery of Cinryze

Enrollment complete in ViroPharma's Phase 2 study evaluating subcutaneous delivery of Cinryze

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

NovaBay delivers two poster presentations on Aganocide compounds at IDSA Annual Meeting

Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint

Intercell's IC43 Phase II trial against Pseudomonas aeruginosa infections meets primary endpoint

Incidence of KPC-producing bacteria is rising in Chicago

Incidence of KPC-producing bacteria is rising in Chicago

UCLA researchers receive grant to develop medical products against radiation exposure

UCLA researchers receive grant to develop medical products against radiation exposure

Vancomycin beneficial for managing patients hospitalized with cellulits

Vancomycin beneficial for managing patients hospitalized with cellulits

Maven Semantic updates Antiviral research database

Maven Semantic updates Antiviral research database

Optimer presents two fidaxomicin Phase 3 trials data for CDI infection at IDSA Annual Meeting

Optimer presents two fidaxomicin Phase 3 trials data for CDI infection at IDSA Annual Meeting

FDA issues complete response letter for ViroPharma's Cinryze

FDA issues complete response letter for ViroPharma's Cinryze

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

Gilead announces results from Phase III clinical trial of Cayston, TIS in cystic fibrosis patients

TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection

TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection

Hospira announces launch of piperacillin and tazobactam injection in the US

Hospira announces launch of piperacillin and tazobactam injection in the US

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

Scientists suggest enzyme that modifies 4-quinolones can reduce microbial infection

Scientists suggest enzyme that modifies 4-quinolones can reduce microbial infection

Aradigm reports positive data from DRCFI, ARD-3150 Phase 2b bronchiectasis study

Aradigm reports positive data from DRCFI, ARD-3150 Phase 2b bronchiectasis study

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

Cubist announces pricing of 2.50% Convertible Senior Notes due 2017

Cubist announces pricing of 2.50% Convertible Senior Notes due 2017

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

CIED implantation with AIGISRx Antibacterial Envelope reduces overall infection rate

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.